ArticleCell death & disease2024

Antitumour effect of the mitochondrial complex III inhibitor Atovaquone in combination with anti-PD-L1 therapy in mouse cancer models.

Gonzalo Rodriguez-Berriguete et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.